1,015 companies
Merck Sharp & Dohme Corp.
Merck & Co., Inc.
New Jersey
MREO
Mereo Biopharma Group Plc
mereo is a new uk-based speciality biopharmaceutical company focussed on the acquisition and rapid development of innovative medicines that have the potential to transform patient quality of life and improve human health.
United Kingdom
NASDAQ
MACK
Merrimack Pharmaceuticals Inc
merrimack is a fully integrated biopharmaceutical company that views cancer as a complex engineering challenge.
Massachusetts
NASDAQ
MRSN
Mersana Therapeutics Inc
mersana is rewriting the rules for immunoconjugate therapies by leveraging our fleximer platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives.
Massachusetts
NASDAQ
MRUS
Merus N.V
merus is developing best-in-class therapeutics to treat and potentially cure cancer patients.
Netherlands
NASDAQ
MTCR
Metacrine, Inc.
Metacrine, Inc.
California
NASDAQ
MIST
Milestone Pharmaceuticals Inc
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
Quebec, Canada
NASDAQ
MLNM
Millennium Pharmaceuticals Inc
Massachusetts
MLYS
Mineralys Therapeutics Inc
at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment.
Pennsylvania
NASDAQ
NERV
Minerva Neurosciences Inc
minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases.
Massachusetts
NASDAQ
MIRA
Mira Pharmaceuticals Inc
MIRA Pharmaceuticals, Inc.
Maryland
NASDAQ
MRTX
Mirati Therapeutics Inc
mirati therapeutics develops molecularly targeted, single agent and immuno-oncology combination therapies intended to treat cancer.
California
NASDAQ
MIRM
Mirum Pharmaceuticals Inc
mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
California
NASDAQ
MTEM
Molecular Templates Inc
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform.
Texas
NASDAQ
MBRX
Moleculin Biotech Inc
moleculin biotech, inc.
Texas
NASDAQ
MNPR
Monopar Therapeutics Inc
monopar therapeutics inc., a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the united states.
Illinois
NASDAQ
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Switzerland
NASDAQ
Moroney John J
MORF
Morphic Holding Inc
oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases.
Massachusetts
NASDAQ
MOR
Morphosys AG
MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US.
Germany
NASDAQ